101 related articles for article (PubMed ID: 25842401)
1. [Elevated levels of circulating immune complexes -C3d and-C1q as a criterion for acute extraintestinal manifestations of ulcerative colitis].
Sagynbaeva VÉ; Lazebnik LB
Eksp Klin Gastroenterol; 2014; (7):18-24. PubMed ID: 25842401
[TBL] [Abstract][Full Text] [Related]
2. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
4. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
5. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
6. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations.
Riccio A; Reynaud L; Postiglione L; Catalano M; Natale D; Pronestì G; Melfa V; Cicciarello S; Borgia G
Boll Soc Ital Biol Sper; 1994; 70(8-9):235-42. PubMed ID: 7893482
[TBL] [Abstract][Full Text] [Related]
8. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
9. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
10. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
Ramanathan VD; Thyagi P; Ramanathan U; Katoch K; Ramu G
Indian J Lepr; 1998; 70(2):153-60. PubMed ID: 9724850
[TBL] [Abstract][Full Text] [Related]
11. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
Swaak AJ; Groenwold J; Hannema A; Hack CE
Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
[TBL] [Abstract][Full Text] [Related]
12. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
13. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
15. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.
Messias-Reason IJ; Hayashi SY; Nisihara RM; Kirschfink M
Clin Exp Immunol; 2002 Feb; 127(2):310-5. PubMed ID: 11876755
[TBL] [Abstract][Full Text] [Related]
17. The possible role of circulating immune complexes in the deficiency of cell-mediated immunity in paracoccidioidomycosis.
Chequer-Bou-Habib D; Oliveira-Neto MP; Ferreira-da-Cruz MF; Galvão-Castro B
Braz J Med Biol Res; 1989; 22(2):205-12. PubMed ID: 2790289
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in chronic hepatitis C.
Tsai JF; Jeng JE; Chang WY; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1995 May; 46(1):12-7. PubMed ID: 7623000
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune system and ulcerative colitis activity. III. Immune complexes.
Hermanowicz A; Sliwiński Z; Borys D
Arch Immunol Ther Exp (Warsz); 1984; 32(5):515-21. PubMed ID: 6152531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
